Application of a clinical decision support tool for predicting biochemical remission with vedolizumab therapy in patients with ulcerative colitis

被引：0
|
作者：
Kim, Kyuwon [1 ]
Oh, Kyunghwan [1 ]
Hong, Hee Seung [1 ]
Lee, Jae Yong [1 ]
Hong, Seung Wook [1 ]
Park, Jin Hwa [1 ]
Hwang, Sung Wook [1 ,2 ]
Park, Sang Hyoung [1 ,2 ]
Yang, Dong-Hoon [1 ]
Byeon, Jeong-Sik [1 ]
Myung, Seung-Jae [1 ]
Yang, Suk-Kyun [1 ,2 ]
Ye, Byong Duk [1 ,2 ]
机构：
[1] Univ Ulsan, Dept Gastroenterol, Coll Med, Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Inflammatory Bowel Dis Ctr, Coll Med, Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 36卷
关键词：
biochemical remission; clinical decision support tool; ulcerative colitis; vedolizumab;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PP-0484
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [1] Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab
    Dulai, Parambir S.
    Wong, Emily C. L.
    Reinisch, Walter
    Colombel, Jean-Frederic
    Marshall, John K.
    Narula, Neeraj
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (10) : 1555 - 1564
  • [2] Clinical and endoscopic remission with vedolizumab treatment in ulcerative colitis
    Almutairdi, A.
    Ma, C.
    Kotze, P. G.
    Al-Damarki, A.
    Devlin, S.
    Kaplan, G.
    Seow, C.
    Novak, K.
    Lu, C.
    Ferraz, J.
    Stewart, M.
    Buresi, M.
    Mathivanan, M.
    Jijon, H.
    Heatherington, J.
    Martin, M. -L.
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S430 - S431
  • [3] DEVELOPMENT AND VALIDATION OF A CLINICAL SCORING TOOL FOR PREDICTING TREATMENT OUTCOMES WITH VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS
    Dulai, Parambir S.
    Singh, Siddharth
    Vande Casteele, Niels
    Meserve, Joseph
    Winters, Adam C.
    Chablaney, Shreya
    Aniwan, Satimai
    Shashi, Preeti
    Kochhar, Gursimran
    Weiss, Aaron
    Koliani-Pace, Jenna
    Gao, Youran
    Boland, Brigid S.
    Chang, John T.
    Faleck, David
    Hirten, Robert
    Ungaro, Ryan C.
    Lukin, Dana
    Keith, Sultan
    Hudesman, David
    Chang, Shannon
    Bohm, Matthew
    Varma, Sashidhar
    Fischer, Monika
    Shmidt, Eugenia
    Swaminath, Arun
    Gupta, Nitin
    Rosario, Maria
    Jairath, Vipul
    Guizzetti, Leonardo
    Feagan, Brian G.
    Siegel, Corey A.
    Shen, Bo
    Kane, Sunanda V.
    Loftus, Edward V.
    Sandborn, William J.
    Sands, Bruce E.
    Colombel, Jean Frederic
    Lasch, Karen
    Cao, Charlie
    GASTROENTEROLOGY, 2019, 156 (06) : S67 - S67
  • [4] Development and validation of a clinical scoring tool for predicting treatment outcomes with vedolizumab in patients with ulcerative colitis
    Dulai, P. S.
    Singh, S.
    Vande Casteele, N.
    Meserve, J.
    Winters, A.
    Chablaney, S.
    Aniwan, S.
    Shashi, P.
    Kochhar, G.
    Weiss, A.
    Koliani-Pace, J. L.
    Gao, Y.
    Boland, B. S.
    Chang, J. T.
    Faleck, D.
    Hirten, R.
    Ungaro, R.
    Lukin, D.
    Sultan, K.
    Hudesman, D.
    Chang, S.
    Bohm, M.
    Varma, S.
    Fischer, M.
    Shmidt, E.
    Swaminath, A.
    Gupta, N.
    Rosario, M.
    Jairath, V.
    Guizzetti, L.
    Feagan, B. G.
    Siegel, C. A.
    Shen, B.
    Kane, S.
    Loftus, E. V., Jr.
    Sandborn, W. J.
    Sands, B. E.
    Colombel, J. -F.
    Lasch, K.
    Cao, C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S433 - S433
  • [5] Application of a clinical decision support tool for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicenter study
    Kim, K.
    Hong, S. W.
    Park, J. H.
    Hwang, S. W.
    Park, S. H.
    Yang, D. H.
    Byeon, J. S.
    Myung, S. J.
    Yang, S. K.
    Yoo, J. H.
    Boo, S. J.
    Kim, E. S.
    Lee, J.
    Kim, K. O.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I503 - I504
  • [6] Application of a clinical decision support tool for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicenter study
    Kim, K.
    Hong, S. W.
    Park, J. H.
    Hwang, S. W.
    Park, S. H.
    Yang, D. H.
    Byeon, J. S.
    Myung, S. J.
    Yang, S. K.
    Yoo, J. H.
    Boo, S. J.
    Kim, E. S.
    Lee, J.
    Kim, K. O.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I503 - I504
  • [7] Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
    Feagan, Brian G.
    Schreiber, Stefan
    Wolf, Douglas C.
    Axler, Jeffrey L.
    Kaviya, Arpeat
    James, Alexandra
    Curtis, Rebecca I.
    Geransar, Parnia
    Stallmach, Andreas
    Ehehalt, Robert
    Bokemeyer, Bernd
    Khalid, Javaria Mona
    O'Byrne, Sharon
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (06) : 1028 - 1035
  • [8] Clinical decision support tool for vedolizumab can predict treatment persistence in Crohn's disease but not in ulcerative colitis
    Ocepek, A.
    Molinari, N.
    Macek, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1847 - I1847
  • [9] Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis
    Waljee, A. K.
    Liu, B.
    Sauder, K.
    Zhu, J.
    Govani, S. M.
    Stidham, R. W.
    Higgins, P. D. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (06) : 763 - 772
  • [10] The systemic immune-inflammation index is superior to predicting clinical remission and relapse for ulcerative colitis patients treated with vedolizumab
    Yan, Jing
    Wu, Jun
    Wang, Rongkun
    Meng, Pin
    Liu, Ailing
    Xu, Yonghong
    FRONTIERS IN MEDICINE, 2025, 12
12345